Lataa...

Alzheimer's disease drug development pipeline: 2019

INTRODUCTION: Alzheimer's disease (AD) has few available treatments, and there is a high rate of failure in AD drug development programs. Study of the AD drug development pipeline can provide insight into the evolution of drug development and how best to optimize development practices. METHODS:...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Dement (N Y)
Päätekijät: Cummings, Jeffrey, Lee, Garam, Ritter, Aaron, Sabbagh, Marwan, Zhong, Kate
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2019
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6617248/
https://ncbi.nlm.nih.gov/pubmed/31334330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2019.05.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!